Impact of Nirsevimab Immunization on Pediatric Hospitalization Rates: A Systematic Review and Meta-Analysis (2024).

From both a clinical and public health point of view, it was particularly frustrating as this study documented the efficacy of nirservimab in a specific and quite significant subset of patients, i.e., admission to PICU [ 87 , 117 , 118 ], the prevention of which would lead to a substantial reduction in the eventual RSV-associated disease burden in terms of both morbidity and direct and indirect costs.

also in 5,705 other papers